Skip to main content

Table 2 Change of circulating inflammatory and endothelial markers

From: Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease

  Control RA IBD
CRP, μg/mL 0.90 (9.50, 2.00) 3.8 (0.7, 7.9)*** 1.70 (0.70, 4.05)*#
IL-1β, pg/mL 0.74 (0.31, 1.23) 0.87 (0.36, 2.95)* 0.71 (0.32, 1.81)
IL-6, pg/mL 0.52 (0.33, 0.80) 1.52 (0.54, 3.37)*** 1.03 (0.56, 1.79)***
IL-10, pg/mL 11.4 (6.6, 18.6) 15.8 (10.7, 38.7)* 19.3 (12.5, 31.3)***
TNF-α, pg/mL 2.32 (1.46, 3.75) 3.29 (1.99, 6.10)* 3.27 (2.18, 4.22)**
MIF, ng/mL 25.7 (21.4, 33.1) 49.3 (39.5, 79.0)** 46.2 (37.6, 58.2)**
vWF, μg/mL 7.56 (5.25, 12.50) 10.83 (7.68,19.36)** 11.32 (7.75,18.15)**
E-selectin + EMP, (/μL) 154 (122, 185) 164 (129, 204) 132(109, 184)
  1. Results were expressed as median (25, 75 percentile). *, **, *** vs. control (p < 0.05, <0.01, <0.001), # vs. RA (p < 0.05). CRP: C-reactive protein; EMP: endothelial microparticles; IBD: inflammatory bowel disease; IL-1β: interleukin-1β; IL-6: interleukin-6; IL-10: interleukin-10; MIF: macrophage migration inhibitory factor; RA: rheumatoid arthritis; TNF-α: tumour necrosis factor-α; vWF: von Willebrand factor.